Literature DB >> 34774847

ZFP36L1 Regulates Fgf21 mRNA Turnover and Modulates Alcoholic Hepatic Steatosis and Inflammation in Mice.

Chandra S Bathula1, Jian Chen1, Rahul Kumar1, Perry J Blackshear2, Yogesh Saini1, Sonika Patial3.   

Abstract

Zinc finger protein 36 like 1 (ZFP36L1) enhances the turnover of mRNAs containing AU-rich elements (AREs) in their 3'-untranslated regions (3'UTR). The physiological and pathological functions of ZFP36L1 in liver, however, remain largely unknown. Liver-specific ZFP36L1-deficient (Zfp36l1flox/flox/Cre+; L1LKO) mice were generated to investigate the role of ZFP36L1 in liver physiology and pathology. Under normal conditions, the L1LKO mice and their littermate controls (Zfp36l1flox/flox/Cre-; L1FLX) appeared normal. When fed a Lieber-DeCarli liquid diet containing alcohol, L1LKO mice were significantly protected from developing alcohol-induced hepatic steatosis, injury, and inflammation compared with L1FLX mice. Most importantly, fibroblast growth factor 21 (Fgf21) mRNA was significantly increased in the livers of alcohol diet-fed L1LKO mice compared with the alcohol diet-fed L1FLX group. The Fgf21 mRNA contains three AREs in its 3'UTR, and Fgf21 3'UTR was directly regulated by ZFP36L1 in luciferase reporter assays. Steady-state levels of Fgf21 mRNA were significantly decreased by wild-type ZFP36L1, but not by a non-binding zinc finger ZFP36L1 mutant. Finally, wild-type ZFP36L1, but not the ZFP36L1 mutant, bound to the Fgf21 3'UTR ARE RNA probe. These results demonstrate that ZFP36L1 inactivation protects against alcohol-induced hepatic steatosis and liver injury and inflammation, possibly by stabilizing Fgf21 mRNA. These findings suggest that the modulation of ZFP36L1 may be beneficial in the prevention or treatment of human alcoholic liver disease.
Copyright © 2022 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34774847      PMCID: PMC8908057          DOI: 10.1016/j.ajpath.2021.10.017

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype.

Authors:  Lian-Qun Qiu; Deborah J Stumpo; Perry J Blackshear
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

Review 2.  Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.

Authors:  Bin Gao
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

3.  Tumor necrosis factor and alcoholic liver disease.

Authors:  C J McClain; S Barve; S Barve; I Deaciuc; D B Hill
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

Review 4.  Tristetraprolin as a Therapeutic Target in Inflammatory Disease.

Authors:  Sonika Patial; Perry J Blackshear
Journal:  Trends Pharmacol Sci       Date:  2016-08-05       Impact factor: 14.819

5.  Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis.

Authors:  Deborah J Stumpo; Hal E Broxmeyer; Toni Ward; Scott Cooper; Giao Hangoc; Yang Jo Chung; William C Shelley; Eric K Richfield; Manas K Ray; Mervin C Yoder; Peter D Aplan; Perry J Blackshear
Journal:  Blood       Date:  2009-07-24       Impact factor: 22.113

6.  Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production.

Authors:  Varsha Thakur; Michele T Pritchard; Megan R McMullen; Qifang Wang; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2006-03-22       Impact factor: 4.962

7.  A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency.

Authors:  G A Taylor; E Carballo; D M Lee; W S Lai; M J Thompson; D D Patel; D I Schenkman; G S Gilkeson; H E Broxmeyer; B F Haynes; P J Blackshear
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

8.  Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies.

Authors:  Sonika Patial; Alan D Curtis; Wi S Lai; Deborah J Stumpo; Georgette D Hill; Gordon P Flake; Mark D Mannie; Perry J Blackshear
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

9.  RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism.

Authors:  Elizabeth J Tarling; Bethan L Clifford; Joan Cheng; Pauline Morand; Angela Cheng; Ellen Lester; Tamer Sallam; Martin Turner; Thomas Q de Aguiar Vallim
Journal:  J Clin Invest       Date:  2017-09-11       Impact factor: 19.456

10.  Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury.

Authors:  Yanlong Liu; Cuiqing Zhao; Jian Xiao; Liming Liu; Min Zhang; Cuiling Wang; Guicheng Wu; Ming-Hua Zheng; Lan-Man Xu; Yong-Ping Chen; Moosa Mohammadi; Shao-Yu Chen; Matthew Cave; Craig McClain; Xiaokun Li; Wenke Feng
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

View more
  1 in total

1.  Beta-hydroxybutyrate dampens adipose progenitors' profibrotic activation through canonical Tgfβ signaling and non-canonical ZFP36-dependent mechanisms.

Authors:  Simon Lecoutre; Fatiha Merabtene; Elie-Julien El Hachem; Camille Gamblin; Christine Rouault; Nataliya Sokolovska; Hedi Soula; Wi S Lai; Perry J Blackshear; Karine Clément; Isabelle Dugail
Journal:  Mol Metab       Date:  2022-05-09       Impact factor: 8.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.